End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported. / French, Eric; McCauley , Jeremy ; Aragon, Maria; Bakx, Pieter; Chalkley, Martin; Chen, Stacey; Christensen, Bent Jesper; Chuang, Hongwei; Cote-Sergent, Aurelie; De Nardi, Mariacristina; Fan, Elliott; Echevin, Damien; Geoffard, Pierre-Yves; Gastaldi-Menager, Christelle; Gørtz, Mette; Ibuka, Yoko; Jones, John B.; Kallestrup-Lamb, Malene; Karlsson, Martin; Klein, Tobias J.; de Lagasnerie, Gregoire; Michaud, Pierre-Carl; O'Donnell, Owen; Rice, Nigel; Skinner, Jonathan S. ; van Doorslaer, Eddy; Ziebarth, Nicholas; Kelly, Elaine.

I: Health Affairs, Bind 36, Nr. 7, 07.2017, s. 1211-1217.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

French, E, McCauley , J, Aragon, M, Bakx, P, Chalkley, M, Chen, S, Christensen, BJ, Chuang, H, Cote-Sergent, A, De Nardi, M, Fan, E, Echevin, D, Geoffard, P-Y, Gastaldi-Menager, C, Gørtz, M, Ibuka, Y, Jones, JB, Kallestrup-Lamb, M, Karlsson, M, Klein, TJ, de Lagasnerie, G, Michaud, P-C, O'Donnell, O, Rice, N, Skinner, JS, van Doorslaer, E, Ziebarth, N & Kelly, E 2017, 'End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported', Health Affairs, bind 36, nr. 7, s. 1211-1217. https://doi.org/10.1377/hlthaff.2017.0174

APA

French, E., McCauley , J., Aragon, M., Bakx, P., Chalkley, M., Chen, S., Christensen, B. J., Chuang, H., Cote-Sergent, A., De Nardi, M., Fan, E., Echevin, D., Geoffard, P-Y., Gastaldi-Menager, C., Gørtz, M., Ibuka, Y., Jones, J. B., Kallestrup-Lamb, M., Karlsson, M., ... Kelly, E. (2017). End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported. Health Affairs, 36(7), 1211-1217. https://doi.org/10.1377/hlthaff.2017.0174

Vancouver

French E, McCauley J, Aragon M, Bakx P, Chalkley M, Chen S o.a. End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported. Health Affairs. 2017 jul.;36(7):1211-1217. https://doi.org/10.1377/hlthaff.2017.0174

Author

French, Eric ; McCauley , Jeremy ; Aragon, Maria ; Bakx, Pieter ; Chalkley, Martin ; Chen, Stacey ; Christensen, Bent Jesper ; Chuang, Hongwei ; Cote-Sergent, Aurelie ; De Nardi, Mariacristina ; Fan, Elliott ; Echevin, Damien ; Geoffard, Pierre-Yves ; Gastaldi-Menager, Christelle ; Gørtz, Mette ; Ibuka, Yoko ; Jones, John B. ; Kallestrup-Lamb, Malene ; Karlsson, Martin ; Klein, Tobias J. ; de Lagasnerie, Gregoire ; Michaud, Pierre-Carl ; O'Donnell, Owen ; Rice, Nigel ; Skinner, Jonathan S. ; van Doorslaer, Eddy ; Ziebarth, Nicholas ; Kelly, Elaine. / End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported. I: Health Affairs. 2017 ; Bind 36, Nr. 7. s. 1211-1217.

Bibtex

@article{b649ff430a3e41e6a56eb131f7da9c4f,
title = "End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported",
abstract = "Although end-of-life medical spending is often viewed as a major component of aggregate medical expenditure, accurate measures of this type of medical spending are scarce. We used detailed health care data for the period 2009–11 from Denmark, England, France, Germany, Japan, the Netherlands, Taiwan, the United States, and the Canadian province of Quebec to measure the composition and magnitude of medical spending in the three years before death. In all nine countries, medical spending at the end of life was high relative to spending at other ages. Spending during the last twelve months of life made up a modest share of aggregate spending, ranging from 8.5 percent in the United States to 11.2 percent in Taiwan, but spending in the last three calendar years of life reached 24.5 percent in Taiwan. This suggests that high aggregate medical spending is due not to last-ditch efforts to save lives but to spending on people with chronic conditions, which are associated with shorter life expectancies.",
author = "Eric French and Jeremy McCauley and Maria Aragon and Pieter Bakx and Martin Chalkley and Stacey Chen and Christensen, {Bent Jesper} and Hongwei Chuang and Aurelie Cote-Sergent and {De Nardi}, Mariacristina and Elliott Fan and Damien Echevin and Pierre-Yves Geoffard and Christelle Gastaldi-Menager and Mette G{\o}rtz and Yoko Ibuka and Jones, {John B.} and Malene Kallestrup-Lamb and Martin Karlsson and Klein, {Tobias J.} and {de Lagasnerie}, Gregoire and Pierre-Carl Michaud and Owen O'Donnell and Nigel Rice and Skinner, {Jonathan S.} and {van Doorslaer}, Eddy and Nicholas Ziebarth and Elaine Kelly",
year = "2017",
month = jul,
doi = "10.1377/hlthaff.2017.0174",
language = "English",
volume = "36",
pages = "1211--1217",
journal = "Health Affairs",
issn = "0278-2715",
publisher = "Project HOPE",
number = "7",

}

RIS

TY - JOUR

T1 - End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported

AU - French, Eric

AU - McCauley , Jeremy

AU - Aragon, Maria

AU - Bakx, Pieter

AU - Chalkley, Martin

AU - Chen, Stacey

AU - Christensen, Bent Jesper

AU - Chuang, Hongwei

AU - Cote-Sergent, Aurelie

AU - De Nardi, Mariacristina

AU - Fan, Elliott

AU - Echevin, Damien

AU - Geoffard, Pierre-Yves

AU - Gastaldi-Menager, Christelle

AU - Gørtz, Mette

AU - Ibuka, Yoko

AU - Jones, John B.

AU - Kallestrup-Lamb, Malene

AU - Karlsson, Martin

AU - Klein, Tobias J.

AU - de Lagasnerie, Gregoire

AU - Michaud, Pierre-Carl

AU - O'Donnell, Owen

AU - Rice, Nigel

AU - Skinner, Jonathan S.

AU - van Doorslaer, Eddy

AU - Ziebarth, Nicholas

AU - Kelly, Elaine

PY - 2017/7

Y1 - 2017/7

N2 - Although end-of-life medical spending is often viewed as a major component of aggregate medical expenditure, accurate measures of this type of medical spending are scarce. We used detailed health care data for the period 2009–11 from Denmark, England, France, Germany, Japan, the Netherlands, Taiwan, the United States, and the Canadian province of Quebec to measure the composition and magnitude of medical spending in the three years before death. In all nine countries, medical spending at the end of life was high relative to spending at other ages. Spending during the last twelve months of life made up a modest share of aggregate spending, ranging from 8.5 percent in the United States to 11.2 percent in Taiwan, but spending in the last three calendar years of life reached 24.5 percent in Taiwan. This suggests that high aggregate medical spending is due not to last-ditch efforts to save lives but to spending on people with chronic conditions, which are associated with shorter life expectancies.

AB - Although end-of-life medical spending is often viewed as a major component of aggregate medical expenditure, accurate measures of this type of medical spending are scarce. We used detailed health care data for the period 2009–11 from Denmark, England, France, Germany, Japan, the Netherlands, Taiwan, the United States, and the Canadian province of Quebec to measure the composition and magnitude of medical spending in the three years before death. In all nine countries, medical spending at the end of life was high relative to spending at other ages. Spending during the last twelve months of life made up a modest share of aggregate spending, ranging from 8.5 percent in the United States to 11.2 percent in Taiwan, but spending in the last three calendar years of life reached 24.5 percent in Taiwan. This suggests that high aggregate medical spending is due not to last-ditch efforts to save lives but to spending on people with chronic conditions, which are associated with shorter life expectancies.

U2 - 10.1377/hlthaff.2017.0174

DO - 10.1377/hlthaff.2017.0174

M3 - Journal article

C2 - 28679807

VL - 36

SP - 1211

EP - 1217

JO - Health Affairs

JF - Health Affairs

SN - 0278-2715

IS - 7

ER -

ID: 179282912